After years of patent protection, biosimilars for Humira are set to enter the US ... designed to decrease injection volume for higher doses and also reduce pain at the injection site.

For comparison, treatment of RA with Humira – which requires regular injections – costs around $60,000 a year. Humira is starting to feel the effects of lower-cost biosimilar competition in ...

Supply for Vabysmo PFS will become available to Canadian ophthalmologists and their patients in the coming months. Roche Canada is committed to continuing to work with the provincial and ...

Supply for Vabysmo PFS will become available to Canadian ophthalmologists and their patients in the coming months. Roche Canada is committed to continuing to work with the provincial and territorial ...

is pleased to announce today that Health Canada has authorized Vabysmo® (faricimab injection) for use in a 6.0 mg single-use pre-filled syringe (PFS) for use in the treatment of wet, or ...